A new family of H3 receptor antagonists based on the natural product Conessine.

PubWeight™: 0.96‹?› | Rank: Top 15%

🔗 View Article (PMID 18194865)

Published in Bioorg Med Chem Lett on December 25, 2007

Authors

Vincent J Santora1, Jonathan A Covel, Rena Hayashi, Brian J Hofilena, Jason B Ibarra, Michelle D Pulley, Michael I Weinhouse, Dipanjan Sengupta, Jonathan J Duffield, Graeme Semple, Robert R Webb, Carleton Sage, Albert Ren, Guilherme Pereira, Jens Knudsen, Jeffrey E Edwards, Marissa Suarez, John Frazer, William Thomsen, Erin Hauser, Kevin Whelan, Andrew J Grottick

Author Affiliations

1: Medicinal Chemistry, Arena Pharmaceuticals, 6166 Nancy Ridge Drive, San Diego, CA 92121, USA.

Articles by these authors

Prebiotic effects: metabolic and health benefits. Br J Nutr (2010) 3.49

Randomised, double-blind, placebo-controlled trial of fructo-oligosaccharides in active Crohn's disease. Gut (2011) 3.11

Hsp70 stabilizes lysosomes and reverts Niemann-Pick disease-associated lysosomal pathology. Nature (2010) 2.62

Lorcaserin, a novel selective human 5-hydroxytryptamine2C agonist: in vitro and in vivo pharmacological characterization. J Pharmacol Exp Ther (2008) 2.17

Pyran annulation: asymmetric synthesis of 2,6-disubstituted-4-methylene tetrahydropyrans. Org Lett (2002) 1.96

A role for beta-cell-expressed G protein-coupled receptor 119 in glycemic control by enhancing glucose-dependent insulin release. Endocrinology (2007) 1.91

Niacin lipid efficacy is independent of both the niacin receptor GPR109A and free fatty acid suppression. Sci Transl Med (2012) 1.71

Stimulation of NF-κB activity by the HIV restriction factor BST2. J Virol (2012) 1.56

Fermentable carbohydrate restriction reduces luminal bifidobacteria and gastrointestinal symptoms in patients with irritable bowel syndrome. J Nutr (2012) 1.51

Differential effects of the 5-HT(2A) receptor antagonist M100907 and the 5-HT(2C) receptor antagonist SB242084 on cocaine-induced locomotor activity, cocaine self-administration and cocaine-induced reinstatement of responding. Neuropsychopharmacology (2002) 1.49

Functional assays for screening GPCR targets. Curr Opin Biotechnol (2005) 1.48

Probiotic and prebiotic use in patients with inflammatory bowel disease: a case-control study. Inflamm Bowel Dis (2010) 1.48

Gastrointestinal microbiota in irritable bowel syndrome: their role in its pathogenesis and treatment. Am J Gastroenterol (2008) 1.44

[The Danish Difficult Airway Registry (DDAR)]. Ugeskr Laeger (2005) 1.40

SLC1 and SLC4 encode partially redundant acyl-coenzyme A 1-acylglycerol-3-phosphate O-acyltransferases of budding yeast. J Biol Chem (2007) 1.33

Hemorrhage-adjusted iron requirements, hematinics and hepcidin define hereditary hemorrhagic telangiectasia as a model of hemorrhagic iron deficiency. PLoS One (2013) 1.28

Discovery and structure-activity relationship of (1R)-8-chloro-2,3,4,5-tetrahydro-1-methyl-1H-3-benzazepine (Lorcaserin), a selective serotonin 5-HT2C receptor agonist for the treatment of obesity. J Med Chem (2007) 1.27

Association between Faecalibacterium prausnitzii and dietary fibre in colonic fermentation in healthy human subjects. Br J Nutr (2010) 1.27

Total synthesis of bryostatin 1. J Am Chem Soc (2010) 1.25

Evolution of the acyl-CoA binding protein (ACBP). Biochem J (2005) 1.23

Smokers with active Crohn's disease have a clinically relevant dysbiosis of the gastrointestinal microbiota. Inflamm Bowel Dis (2011) 1.22

A role for interferon-gamma in focal cerebral ischemia in mice. J Neuropathol Exp Neurol (2004) 1.21

Evidence for the use of probiotics and prebiotics in inflammatory bowel disease: a review of clinical trials. Proc Nutr Soc (2007) 1.20

Nicotinic acid receptor agonists differentially activate downstream effectors. J Biol Chem (2007) 1.16

Discovery of the first potent and orally efficacious agonist of the orphan G-protein coupled receptor 119. J Med Chem (2008) 1.16

International Union of Basic and Clinical Pharmacology. LXXXII: Nomenclature and Classification of Hydroxy-carboxylic Acid Receptors (GPR81, GPR109A, and GPR109B). Pharmacol Rev (2011) 1.11

Lipid-binding proteins and lipoprotein lipase activity in human skeletal muscle: influence of physical activity and gender. J Appl Physiol (1985) (2004) 1.11

The diagnostic value of PET/CT scanning in patients with cervical cancer: a prospective study. Gynecol Oncol (2007) 1.10

Family studies in Crohn's disease: new horizons in understanding disease pathogenesis, risk and prevention. Gut (2011) 1.05

Anxiolytic- and antidepressant-like profile of ATC0065 and ATC0175: nonpeptidic and orally active melanin-concentrating hormone receptor 1 antagonists. J Pharmacol Exp Ther (2005) 1.01

Nutritional problems in inflammatory bowel disease: the patient perspective. J Crohns Colitis (2011) 1.01

Compromised mitochondrial fatty acid synthesis in transgenic mice results in defective protein lipoylation and energy disequilibrium. PLoS One (2012) 1.00

1-Alkyl-benzotriazole-5-carboxylic acids are highly selective agonists of the human orphan G-protein-coupled receptor GPR109b. J Med Chem (2006) 0.99

The mechanisms and efficacy of probiotics in the prevention of Clostridium difficile-associated diarrhoea. Lancet Infect Dis (2009) 0.97

Antimalarial activities of novel synthetic cysteine protease inhibitors. Antimicrob Agents Chemother (2003) 0.97

Yeast sphingolipids do not need to contain very long chain fatty acids. Biochem J (2007) 0.97

Agonist lead identification for the high affinity niacin receptor GPR109a. Bioorg Med Chem Lett (2007) 0.97

Aureobasidin A arrests growth of yeast cells through both ceramide intoxication and deprivation of essential inositolphosphorylceramides. Mol Microbiol (2009) 0.96

Transient intermediary states with high and low folding probabilities in the apparent two-state folding equilibrium of ACBP at low pH. J Mol Biol (2002) 0.96

Acyl-CoA-binding protein, Acb1p, is required for normal vacuole function and ceramide synthesis in Saccharomyces cerevisiae. Biochem J (2004) 0.96

Acyl-CoA binding proteins; structural and functional conservation over 2000 MYA. Mol Cell Biochem (2007) 0.94

Effects of a niacin receptor partial agonist, MK-0354, on plasma free fatty acids, lipids, and cutaneous flushing in humans. J Clin Lipidol (2008) 0.94

MAA-1, a novel acyl-CoA-binding protein involved in endosomal vesicle transport in Caenorhabditis elegans. Mol Biol Cell (2006) 0.93

Azathioprine therapy selectively ablates human Vδ2⁺ T cells in Crohn's disease. J Clin Invest (2015) 0.91

Pre-synaptic modulation of quadriceps arthrogenic muscle inhibition. Knee Surg Sports Traumatol Arthrosc (2005) 0.91

Transcriptional regulation of phospholipid biosynthesis is linked to fatty acid metabolism by an acyl-CoA-binding-protein-dependent mechanism in Saccharomyces cerevisiae. Biochem J (2007) 0.91

Reliability of an electrical method to induce muscle cramp. Muscle Nerve (2003) 0.90

Aging reduces glycerol-3-phosphate acyltransferase activity in activated rat splenic T-lymphocytes. Biochim Biophys Acta (2005) 0.90

Fiber in the treatment and maintenance of inflammatory bowel disease: a systematic review of randomized controlled trials. Inflamm Bowel Dis (2014) 0.90

Comparison of complications attributable to enteral and parenteral nutrition in predicted severe acute pancreatitis: a systematic review and meta-analysis. Br J Nutr (2010) 0.90

Quantitative profiling of PE, MMPE, DMPE, and PC lipid species by multiple precursor ion scanning: a tool for monitoring PE metabolism. Biochim Biophys Acta (2011) 0.89

Phencyclidine exacerbates attentional deficits in a neurodevelopmental rat model of schizophrenia. Neuropsychopharmacology (2003) 0.89

Top dietary iron sources in the UK. Br J Gen Pract (2014) 0.89

Compositional and structural characterization of monolayers and bilayers composed of native pulmonary surfactant from wild type mice. Biochim Biophys Acta (2013) 0.89

The potential use of selective 5-HT2C agonists in treating obesity. Expert Opin Investig Drugs (2006) 0.88

Acyl-CoA binding protein is an essential protein in mammalian cell lines. Biochem J (2002) 0.88

Effects of resistance training on resistin, leptin, cytokines, and muscle force in elderly post-menopausal women. J Sports Sci (2009) 0.88

Acyl-CoA binding protein expression is fiber type- specific and elevated in muscles from the obese insulin-resistant Zucker rat. Diabetes (2002) 0.88

Effects of a P-glycoprotein inhibitor on brain and plasma concentrations of anti-human immunodeficiency virus drugs administered in combination in rats. Drug Metab Dispos (2002) 0.87

Threshold frequency of an electrically induced cramp increases following a repeated, localized fatiguing exercise. J Sports Sci (2010) 0.87

Aging and acyl-CoA binding protein alter mitochondrial glycerol-3-phosphate acyltransferase activity. Biochim Biophys Acta (2003) 0.87

Arthrogenic muscle inhibition is not present in the limb contralateral to a simulated knee joint effusion. Am J Phys Med Rehabil (2003) 0.87

Fused tricyclic indoles as S1P₁ agonists with robust efficacy in animal models of autoimmune disease. Bioorg Med Chem Lett (2012) 0.87

Long-chain Acyl-CoA is not primarily increased in myotubes established from type 2 diabetic subjects. Biochim Biophys Acta (2006) 0.86

Different secondary structure elements as scaffolds for protein folding transition states of two homologous four-helix bundles. Proteins (2005) 0.86

Preliminary comparison of bromelain and Ibuprofen for delayed onset muscle soreness management. Clin J Sport Med (2002) 0.86

Potent tricyclic pyrazole tetrazole agonists of the nicotinic acid receptor (GPR109a). Bioorg Med Chem Lett (2010) 0.86

G protein-coupled receptors as therapeutic targets for obesity and type 2 diabetes. Curr Opin Investig Drugs (2004) 0.86

Regulation of lipolytic activity by long-chain acyl-coenzyme A in islets and adipocytes. Am J Physiol Endocrinol Metab (2005) 0.85

Exercise-associated muscle cramps: causes, treatment, and prevention. Sports Health (2010) 0.85

Acyl-CoA-binding protein (ACBP) localizes to the endoplasmic reticulum and Golgi in a ligand-dependent manner in mammalian cells. Biochem J (2008) 0.84

Discovery of fused bicyclic agonists of the orphan G-protein coupled receptor GPR119 with in vivo activity in rodent models of glucose control. Bioorg Med Chem Lett (2011) 0.84

Fermentable Carbohydrate Restriction (Low FODMAP Diet) in Clinical Practice Improves Functional Gastrointestinal Symptoms in Patients with Inflammatory Bowel Disease. Inflamm Bowel Dis (2016) 0.83

Hospital inpatients' experiences of access to food: a qualitative interview and observational study. Health Expect (2008) 0.83

Proinflammatory Vδ2+ T cells populate the human intestinal mucosa and enhance IFN-γ production by colonic αβ T cells. J Immunol (2013) 0.83

Fluorescently labelled bovine acyl-CoA-binding protein acting as an acyl-CoA sensor: interaction with CoA and acyl-CoA esters and its use in measuring free acyl-CoA esters and non-esterified fatty acids. Biochem J (2002) 0.83

APD791, 3-methoxy-n-(3-(1-methyl-1h-pyrazol-5-yl)-4-(2-morpholinoethoxy)phenyl)benzamide, a novel 5-hydroxytryptamine 2A receptor antagonist: pharmacological profile, pharmacokinetics, platelet activity and vascular biology. J Pharmacol Exp Ther (2009) 0.83

Taste preferences for oral nutrition supplements in patients before and after pelvic radiotherapy: a double-blind controlled study. Clin Nutr (2006) 0.83

Occurrence of refeeding syndrome in adults started on artificial nutrition support: prospective cohort study. BMJ Open (2013) 0.83

Characterization of yeast mutants lacking alkaline ceramidases YPC1 and YDC1. FEMS Yeast Res (2014) 0.82

Nicotinic acid receptor agonists. J Med Chem (2008) 0.82

Kinetics of 5-HT2B receptor signaling: profound agonist-dependent effects on signaling onset and duration. J Pharmacol Exp Ther (2013) 0.82

Etiology of perianal Crohn's disease: role of genetic, microbiological, and immunological factors. Inflamm Bowel Dis (2009) 0.82

Yeast cells lacking all known ceramide synthases continue to make complex sphingolipids and to incorporate ceramides into glycosylphosphatidylinositol (GPI) anchors. J Biol Chem (2010) 0.81

Design and evaluation of novel biphenyl sulfonamide derivatives with potent histamine H(3) receptor inverse agonist activity. J Med Chem (2009) 0.81